Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_1
4
100%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 14 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

NCT04803305
completedphase_1

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

NCT04299048
completedphase_1

Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants

NCT03974776
completedphase_1

Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects

NCT03599063

Clinical Trials (4)

Showing 4 of 4 trials
NCT04803305Phase 1

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Completed
NCT04299048Phase 1

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Completed
NCT03974776Phase 1

Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants

Completed
NCT03599063Phase 1

Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4